ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
113.32
+1.86 (1.67%)
At close: Feb 3, 2026, 4:00 PM EST
113.58
+0.26 (0.23%)
After-hours: Feb 3, 2026, 7:53 PM EST
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $8.87 billion as of February 3, 2026. Its market cap has increased by 2,141.51% in one year.
Market Cap
8.87B
Enterprise Value
8.26B
1-Year Change
2,141.51%
Ranking
Category
Stock Price
$113.32
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $8.87B, an increase of 3,835.13%. That is a compound annual growth rate of 41.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 8.61B | -21.76% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avidity Biosciences | 10.93B |
| BioMarin Pharmaceutical | 10.86B |
| Jazz Pharmaceuticals | 10.00B |
| Bio-Techne | 9.99B |
| Arrowhead Pharmaceuticals | 9.71B |
| Axsome Therapeutics | 9.29B |
| Praxis Precision Medicines | 8.71B |
| Halozyme Therapeutics | 8.43B |